Published in Am J Physiol on September 01, 1982
Metabolic impact of sex hormones on obesity. Brain Res (2010) 1.30
The role of hypothalamic estrogen receptors in metabolic regulation. Front Neuroendocrinol (2014) 0.93
Hypothalamic paraventricular nucleus lesion involvement in the sympathetic control of lipid mobilization. Obesity (Silver Spring) (2009) 0.90
Counterregulation of insulin by leptin as key component of autonomic regulation of body weight. World J Diabetes (2014) 0.79
Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med (2001) 20.18
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93
Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med (2001) 3.56
Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev (1979) 3.36
Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism (2001) 3.25
Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr (2001) 3.12
Definition, measurement, and classification of the syndromes of obesity. Int J Obes (1978) 2.69
The relation of gender, race and socioeconomic status to obesity and obesity comorbidities in a sample of US adults. Int J Obes Relat Metab Disord (2002) 2.64
Complications of obesity. Ann Intern Med (1985) 2.55
Dietary obesity in adult rats: similarities to hypothalamic and human obesity syndromes. Physiol Behav (1976) 2.20
Assessment of energy intake underreporting by doubly labeled water and observations on reported nutrient intakes in children. J Am Diet Assoc (1998) 2.18
Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res (1973) 2.17
The Zucker-fatty rat: a review. Fed Proc (1977) 2.04
First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes. Int J Obes (Lond) (2008) 1.99
Effect of caloric restriction on energy expenditure in obese patients. Lancet (1969) 1.86
A short history of beverages and how our body treats them. Obes Rev (2008) 1.77
Differential oxidation of individual dietary fatty acids in humans. Am J Clin Nutr (2000) 1.62
Genetically transmitted obesity in rodents. Physiol Rev (1971) 1.61
Overweight is risking fate. Definition, classification, prevalence, and risks. Ann N Y Acad Sci (1987) 1.61
Fat and carbohydrate balances during adaptation to a high-fat. Am J Clin Nutr (2000) 1.60
Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine. Obes Res (1999) 1.58
Suppression of appetite by bile acids. Lancet (1968) 1.56
Diurnal variation in glucose tolerance. Cyclic suppression of insulin action and insulin secretion in normal-weight, but not obese, subjects. Diabetes (1992) 1.56
Effects of age, sex, and prior body weight on the development of dietary obesity in adult rats. Physiol Behav (1977) 1.54
A dietary approach to prevent hypertension: a review of the Dietary Approaches to Stop Hypertension (DASH) Study. Clin Cardiol (1999) 1.52
Skinfold thickness measurements in obese subjects. Am J Clin Nutr (1990) 1.45
Chamber for indirect calorimetry with accurate measurement and time discrimination of metabolic plateaus of over 20 min. Med Biol Eng Comput (2003) 1.44
Dietary fat affects obesity rate. Am J Clin Nutr (1999) 1.42
Does vegetable oil attenuate the beneficial effects of fish oil in reducing risk factors for cardiovascular disease? Am J Clin Nutr (1997) 1.42
The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research Group. J Am Diet Assoc (1999) 1.40
Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study. Diabetologia (2009) 1.39
Barriers to the treatment of obesity. Ann Intern Med (1991) 1.39
The Prader-Willi syndrome: a study of 40 patients and a review of the literature. Medicine (Baltimore) (1983) 1.39
Manifestations of hypothalamic obesity in man: a comprehensive investigation of eight patients and a reveiw of the literature. Medicine (Baltimore) (1975) 1.39
Stimulated C-peptide and glucose levels as metabolic criteria to use insulin treatment in adult-onset type II diabetes. Endocr Pract (2004) 1.38
Rats show only a weak preference for the artificial sweetener aspartame. Physiol Behav (1986) 1.36
Healthy Eating Index and obesity. Eur J Clin Nutr (2004) 1.30
Effects of corticotropin-releasing factor on food intake and brown adipose tissue thermogenesis in rats. Am J Physiol (1988) 1.29
Reproductive hormonal function in the genetically obese (ob/ob) mouse. Endocrinology (1976) 1.28
Experimental obesity: a homeostatic failure due to defective nutrient stimulation of the sympathetic nervous system. Vitam Horm (1989) 1.27
Low serum testosterone and sex-hormone-binding-globulin in massively obese men. J Clin Endocrinol Metab (1977) 1.26
Qualitative differences in polysaccharide and sugar tastes in the rat: a two-carbohydrate taste model. Neurosci Biobehav Rev (1987) 1.26
The association of body weight, dietary intake, and energy expenditure with dietary restraint and disinhibition. Obes Res (1995) 1.24
Potent and selective agonism of the melanocortin receptor 4 with MK-0493 does not induce weight loss in obese human subjects: energy intake predicts lack of weight loss efficacy. Clin Pharmacol Ther (2009) 1.24
North-American twins with IDDM. Genetic, etiological, and clinical significance of disease concordance according to age, zygosity, and the interval after diagnosis in first twin. Diabetes (1993) 1.24
Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. Am J Physiol (1991) 1.23
Carbohydrate taste, appetite, and obesity: an overview. Neurosci Biobehav Rev (1987) 1.23
Association of body mass with dietary restraint and disinhibition. Appetite (1995) 1.22
Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women--a clinical research center study. J Clin Endocrinol Metab (1996) 1.20
Topical fat reduction. Obes Res (1995) 1.19
The thermic effect of food and obesity: a critical review. Obes Res (1997) 1.19
Prediction of energy expenditure in a whole body indirect calorimeter at both low and high levels of physical activity. Int J Obes Relat Metab Disord (2001) 1.18
Experience with jejunoileal bypass for obesity. Surg Gynecol Obstet (1976) 1.18
Basic and clinical aspects of regional fat distribution. Am J Clin Nutr (1990) 1.17
Flavor preferences conditioned by intragastric fructose and glucose: differences in reinforcement potency. Physiol Behav (2001) 1.15
Flavor preferences conditioned by intragastric polycose infusions: a detailed analysis using an electronic esophagus preparation. Physiol Behav (1990) 1.15
Colonic pseudo-obstruction: a new complication of jejunoileal bypass. Gut (1975) 1.15
Long-term calorie restriction reduces energy expenditure in aging monkeys. J Gerontol A Biol Sci Med Sci (1999) 1.14
D1 but not D2 dopamine receptor antagonism blocks the acquisition of a flavor preference conditioned by intragastric carbohydrate infusions. Pharmacol Biochem Behav (2001) 1.13
Use of anthropometric measures to assess weight loss. Am J Clin Nutr (1978) 1.11
Dietary Approaches to Stop Hypertension: rationale, design, and methods. DASH Collaborative Research Group. J Am Diet Assoc (1999) 1.11
Fat distribution and body weight. Obes Res (1993) 1.10
Altered body composition in type 2 diabetes mellitus. Int J Obes (Lond) (2008) 1.10
Metabolic factors in the control of energy stores. Metabolism (1975) 1.10
Macronutrient diet intake of the lethal yellow agouti (Ay/a) mouse. Physiol Behav (1999) 1.08
Dietary fat preferences are inversely correlated with peripheral gustatory fatty acid sensitivity. Ann N Y Acad Sci (1998) 1.08
Pharmacology of flavor preference conditioning in sham-feeding rats: effects of dopamine receptor antagonists. Pharmacol Biochem Behav (2000) 1.06
The age of obesity. Int J Obes (1977) 1.06
Diurnal rhythm for corticosterone in obese (ob/ob) diabetes (db/db) and gold-thioglucose-induced obesity in mice. Endocrinology (1983) 1.06
Flavor preferences conditioned by intragastric sugar infusions in rats: maltose is more reinforcing than sucrose. Physiol Behav (1998) 1.06
Conditioned flavor preference and aversion: role of the lateral hypothalamus. Behav Neurosci (2001) 1.05
Intestinal adaptation after jejunoileal bypass in man. Am J Clin Nutr (1977) 1.04
Intracerebroventricular infusions of 3-OHB and insulin in a rat model of dietary obesity. Am J Physiol (1988) 1.03
Pharmacology of flavor preference conditioning in sham-feeding rats: effects of naltrexone. Pharmacol Biochem Behav (1999) 1.03
Hyperinsulinemia and insulin resistance in genetically obese rats. Metabolism (1972) 1.03
Role of D(1) and D(2) dopamine receptors in the acquisition and expression of flavor-preference conditioning in sham-feeding rats. Pharmacol Biochem Behav (2000) 1.03
Effects of epinephrine on glucose transport and metabolism in adipose tissue of normal and hypothyroid rats. J Lipid Res (1968) 1.02
Adrenalectomy reverses insulin resistance in muscle from obese (ob/ob) mice. Am J Physiol (1984) 1.02
Relationship of dietary fat and serum cholesterol ester and phospholipid fatty acids to markers of insulin resistance in men and women with a range of glucose tolerance. Metabolism (2001) 1.02
Differential effects of baseline macronutrient preferences on macronutrient selection after galanin, NPY, and an overnight fast. Peptides (1997) 1.02
Dietary fat-induced hyperphagia in rats as a function of fat type and physical form. Physiol Behav (1989) 1.02
Differential reinforcing and satiating effects of intragastric fat and carbohydrate infusions in rats. Physiol Behav (1999) 1.02
Acetylation alters the feeding response to MSH and beta-endorphin. Brain Res Bull (1989) 1.02
Afferent projections to the dorsal motor nucleus of the vagus. Brain Res Bull (1980) 1.02
Intestinal bypass surgery for obesity decreases food intake and taste preferences. Am J Clin Nutr (1976) 1.01
Species differences in polysaccharide and sugar taste preferences. Neurosci Biobehav Rev (1987) 1.01
Sham-feeding response of rats to Polycose and sucrose. Neurosci Biobehav Rev (1987) 1.01
Concurrent physical activity increases fat oxidation during the shift to a high-fat diet. Am J Clin Nutr (2000) 1.01
Ventilatory responses to the metabolic acidosis of treadmill and cycle ergometry. J Appl Physiol (1976) 1.01
Underreporting of energy intake in biracial children is verified by doubly labeled water. J Am Diet Assoc (1996) 1.01
Autonomic and endocrine factors in the regulation of food intake. Brain Res Bull (1985) 1.01
Hypothalamic obesity. The autonomic hypothesis and the lateral hypothalamus. Diabetologia (1981) 1.00
Naltrexone fails to block the acquisition or expression of a flavor preference conditioned by intragastric carbohydrate infusions. Pharmacol Biochem Behav (2000) 1.00
Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study. J Hypertens (2001) 1.00
Some effects of adrenalectomy in the fatty rat. Endocrinology (1978) 1.00
Obesity. Part I--Pathogenesis. West J Med (1988) 1.00
Fluoxetine treatment of the obese diabetic. Int J Obes Relat Metab Disord (1992) 1.00
Functional correlations between lateral hypothalamic glucose-sensitive neurons and hepatic portal glucose-sensitive units in rat. Brain Res (1983) 1.00
Differential inhibition of fat intake in two strains of rat by the peptide enterostatin. Am J Physiol (1992) 0.99
The effects of subdiaphragmatic vagotomy in rats with ventromedial hypothalamic obesity. Endocrinology (1977) 0.99